Cardinal Health (NYSE:CAH) dropped slightly amid mild profit booking and the last known price was $78.2 per share. The price decreased by -0.33 points or -0.42% which made the investors to buy on weakness. For the latest trading session, the net money flow was recorded at $8.88 million. The total upticks were valued at $33.68 million and the total downticks aggregated to $24.81 million, thereby putting the up/down ratio at 1.36,. The shares have seen a change in the share price of -1.99% on a weekly basis.In a big block trade which occurred today, the total uptick value was $7.71 million and the total downtick value was $0, resulting in an up/down ratio of 0. The net money flow for the block trade was calculated to be $7.71 million.
Currently the company Insiders own 0.97% of Cardinal Health shares according to the proxy statements. Institutional Investors own 86.35% of Cardinal Health shares. On the companys insider trading activities, The Securities and Exchange Commission has divulged that Watkins Carole S, officer (Chief HR Officer) of Cardinal Health Inc, had unloaded 84,617 shares at an average price of $77.33 in a transaction dated on May 20, 2016. The total value of the transaction was worth $6,543,433.
Cardinal Health (NYSE:CAH) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.33 points or 0.42% at $78.2 with 2,042,115 shares getting traded. Post opening the session at $78.53, the shares hit an intraday low of $78.145 and an intraday high of $78.79 and the price was in this range throughout the day. The company has a market cap of $25,479 million and the number of outstanding shares have been calculated to be 325,815,310 shares. The 52-week high of Cardinal Health (NYSE:CAH) is $91.225 and the 52-week low is $74.73.
Many analysts have stated their opinion on the company shares. Bank of America reinstates its view on Cardinal Health (NYSE:CAH) according to the research report released by the firm to its investors. The shares have now been rated Neutral by the stock experts at the ratings house. The rating by the firm was issued on June 7, 2016.
Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.